These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. Li Z, Wang Y, Zhao X, Liu L, Wang D, Wang C, Meng X, Li H, Pan Y, Wang X, Wang C, Yang X, Zhang C, Jing J, Xian Y, Johnston SC, Wang Y, CHANCE Investigators. J Am Heart Assoc; 2016 Mar 21; 5(3):e003038. PubMed ID: 27001965 [Abstract] [Full Text] [Related]
6. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators. N Engl J Med; 2006 Apr 20; 354(16):1706-17. PubMed ID: 16531616 [Abstract] [Full Text] [Related]
7. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C. Cerebrovasc Dis; 2015 Apr 20; 39(1):13-22. PubMed ID: 25547900 [Abstract] [Full Text] [Related]
9. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R, PRoFESS Study Group. Stroke; 2010 Apr 20; 41(4):732-8. PubMed ID: 20181679 [Abstract] [Full Text] [Related]
10. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Martí-Fàbregas J, Bernstein RA, Johnston SC. JAMA Netw Open; 2019 Sep 04; 2(9):e1910769. PubMed ID: 31490536 [Abstract] [Full Text] [Related]
11. The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial. Deng QQ, Tang J, Chen C, Markus H, Huang YN, Zhao H, Ratanakorn D, Wong KS, Fu JH. J Neurol Sci; 2016 Aug 15; 367():18-21. PubMed ID: 27423556 [Abstract] [Full Text] [Related]
15. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Diener HC, Sacco R, Yusuf S, Steering Committee, PRoFESS Study Group. Cerebrovasc Dis; 2007 Aug 15; 23(5-6):368-80. PubMed ID: 17337887 [Abstract] [Full Text] [Related]
16. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial. Jing J, Meng X, Zhao X, Liu L, Wang A, Pan Y, Li H, Wang D, Johnston SC, Wang Y, Wang Y. JAMA Neurol; 2018 Jun 01; 75(6):711-719. PubMed ID: 29582084 [Abstract] [Full Text] [Related]
17. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. Wang Y, Pan Y, Zhao X, Li H, Wang D, Johnston SC, Liu L, Meng X, Wang A, Wang C, Wang Y, CHANCE Investigators. Circulation; 2015 Jul 07; 132(1):40-6. PubMed ID: 25957224 [Abstract] [Full Text] [Related]